Arkema Divests Phosphorus Derivatives Business
Arkema has announced the proposed divestment of Febex, a company specializing in phosphorus-based chemistry, to Belgian group Prayon.
Arkema has proposed the divestment of Febex, a global player in phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives), used primarily in electronics and in the pharmaceuticals industry. Part of the Performance Additives Business Line and with little integration within the Group’s other activities, Febex reported sales of around €30 million in 2021, employs 59 people, and operates 1 site in Switzerland.
Febex will join Prayon, an Belgian industrial group specializing in phosphorus-based chemistry.
The divestment is expected to be finalized in 1st quarter 2023, and is subject to information and prior consultation process with employee representative bodies in France and to approval by the relevant Swiss authorities.
Related Content
-
PCI Names 2023 Board of Directors, Executive Officers
The next individuals serving on PCI's board of directors and as executive officers have been selected.
-
AkzoNobel Uses VR for Training Airline Apprentices
The virtual reality technology provides a paint booth and spray gun that enables trainees to work and master their skills without losing parts in the process.
-
Attentive Employees Support Large Customer Base
As a Products Finishing Top Shop, this company’s success with offering a variety of finishing services would not be possible without its employee dedication and the pride that’s been instilled in them to produce quality products for its long list of customers.
